In summary, TCF3 can bind to HDAC3 to downregulate miR-101 expression, which in turn regulates Akt/mTOR signaling pathway activity, thereby inhibiting the proliferation of BL cells and promoting cell apoptosis. The gene discussed is MTOR; the disease is Burkitt lymphoma.